Multiple carcinoma in patients with psoriasis caused by psoralen-ultraviolet A therapy, natural killer cell insufficiency, or intensified sun exposure?

Cutis. 1992 Jun;49(6):430-2.

Abstract

A case is presented of a patient with psoriasis in whom squamous cell carcinoma most likely occurred due to the interaction of various factors (psoralen-ultraviolet A therapy, sun exposure, and suppression of natural killer cell function). Therapy consisted of 1 mg/kg/daily of etretinate (Tegison), which resulted in clearing of psoriatic lesions in one month's time. New carcinomas did not develop and natural killer function improved.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Carcinoma, Squamous Cell / etiology
  • Carcinoma, Squamous Cell / pathology
  • Etretinate / therapeutic use
  • Humans
  • Killer Cells, Natural / immunology*
  • Male
  • Neoplasms, Multiple Primary / etiology
  • Neoplasms, Multiple Primary / pathology
  • Neoplasms, Radiation-Induced / etiology*
  • Neoplasms, Radiation-Induced / pathology
  • Photochemotherapy / adverse effects*
  • Psoriasis / drug therapy*
  • Psoriasis / immunology
  • Skin Neoplasms / etiology*
  • Skin Neoplasms / pathology
  • Sunlight / adverse effects*

Substances

  • Etretinate